Meanwhile, it is widely accepted that TGF-β signaling is a primary EMT inducer by activation of Smad complexes that translocate into the nucleus to regulate gene expression [7], which is critical for breast cancer progression and heterogeneity [8]. This evidence concerns the gene TGFB1 and breast carcinoma.